Open AccessPrevalence of dyslipidemia and dysglycaemia in HIV infected patients
Author(s) -
E. Manuthu,
MitaV Joshi,
G N Lule,
E M Karari
Publication year - 2008
Publication title -
east african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.102
H-Index - 40
ISSN - 0012-835X
DOI - 10.4314/eamj.v85i1.9600
Subject(s) - medicine , dyslipidemia , stavudine , efavirenz , nevirapine , lamivudine , diabetes mellitus , impaired fasting glucose , gastroenterology , impaired glucose tolerance , viral load , human immunodeficiency virus (hiv) , obesity , antiretroviral therapy , insulin resistance , endocrinology , immunology , chronic hepatitis , virus
Highly active antiretroviral therapy (HAART) has dramatically reduced AIDS morbidity and mortality, however long-term metabolic consequences including dysglycaemia and dyslipidemia have raised concern regarding accelerated cardiovascular disease risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom